# OnCo record lindis-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/lindis-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "lindis-biotech" ;
  schema:name "Lindis Biotech"@en ;
  schema:alternateName "LINDIS Biotech GmbH"@en ;
  schema:description "Lindis Biotech is the German company that took over catumaxomab, the trifunctional antibody once sold as Removab for malignant ascites, and brought it back to regulators after its earlier withdrawal."@en ;
  schema:url <https://onco.cc/companies/lindis-biotech/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "DE" ;
  onco:drugs <https://onco.cc/drugs/catumaxomab/> .
